151 related articles for article (PubMed ID: 29130225)
1. [Conversion therapy of advanced gastric cancer].
Cheng X; Mao Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1127-1130. PubMed ID: 29130225
[TBL] [Abstract][Full Text] [Related]
2. [Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
Liu N; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):983-5. PubMed ID: 26499140
[TBL] [Abstract][Full Text] [Related]
3. [The conversion therapy for unresectable gastric cancer].
Chen L; Ma LG; Xi HQ
Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):169-71. PubMed ID: 26932882
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance and practice points of conversion therapy for gastric cancer with peritoneal metastasis].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1094-1098. PubMed ID: 29130218
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
Morant R
Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
9. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Stage IV Gastric Cancer Curative Resection by Conversion Therapy].
Sano H; Yamaguchi K; Tanahashi T; Sakuratani T; Mori R; Matsui S; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Osada S; Yoshida K
Gan To Kagaku Ryoho; 2018 Mar; 45(3):465-467. PubMed ID: 29650906
[TBL] [Abstract][Full Text] [Related]
12. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in multimodal treatment for gastric cancer: a review.
Lordick F; Siewert JR
Gastric Cancer; 2005; 8(2):78-85. PubMed ID: 15864714
[TBL] [Abstract][Full Text] [Related]
14. Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Du R; Hu P; Liu Q; Zhang J
Cancer Invest; 2019; 37(1):16-28. PubMed ID: 30632817
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized Phase II trial (LANDSCOPE trial).
Yoshikawa T; Fukunaga T; Taguri M; Kunisaki C; Sakuramoto S; Ito S; Morita S; Tsuburaya A
Jpn J Clin Oncol; 2012 Jul; 42(7):654-7. PubMed ID: 22547727
[TBL] [Abstract][Full Text] [Related]
16. [Curative resection of advanced gastric cancer responding to preoperative chemotherapy--a case report].
Kobayashi M; Kasakura Y; Fujii M; Mochizuki F; Kochi M; Eguchi T; Imai S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):527-30. PubMed ID: 11329789
[TBL] [Abstract][Full Text] [Related]
17. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
Yoshikawa T; Morita S; Tanabe K; Nishikawa K; Ito Y; Matsui T; Fujitani K; Kimura Y; Fujita J; Aoyama T; Hayashi T; Cho H; Tsuburaya A; Miyashita Y; Sakamoto J
Eur J Cancer; 2016 Jul; 62():103-11. PubMed ID: 27244537
[TBL] [Abstract][Full Text] [Related]
18. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
Lygidakis NJ; Sgourakis G; Aphinives P
Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.
Oki E; Emi Y; Kusumoto T; Sakaguchi Y; Yamamoto M; Sadanaga N; Shimokawa M; Yamanaka T; Saeki H; Morita M; Takahashi I; Hirabayashi N; Sakai K; Orita H; Aishima S; Kakeji Y; Yamaguchi K; Yoshida K; Baba H; Maehara Y
Ann Surg Oncol; 2014 Jul; 21(7):2340-6. PubMed ID: 24604583
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
